| 000 | 01484 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515222453.0 | ||
| 264 | 0 | _c20100622 | |
| 008 | 201006s 0 0 eng d | ||
| 022 | _a1095-6859 | ||
| 024 | 7 |
_a10.1016/j.ygyno.2010.03.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCadron, Isabelle | |
| 245 | 0 | 0 |
_aThe impact of enzastaurin (LY317615.HCl) on CA125 biosynthesis and shedding in ovarian cancer cells. _h[electronic resource] |
| 260 |
_bGynecologic oncology _cJul 2010 |
||
| 300 |
_a64-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCA-125 Antigen _xbiosynthesis |
| 650 | 0 | 4 |
_aCarboplatin _xpharmacology |
| 650 | 0 | 4 |
_aCell Growth Processes _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xpharmacology |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPaclitaxel _xpharmacology |
| 700 | 1 | _aVan Gorp, Toon | |
| 700 | 1 | _aMihalyi, Attila | |
| 700 | 1 | _aLuyten, Catherina | |
| 700 | 1 | _aDrijkoningen, Katrien | |
| 700 | 1 | _aAmant, Frederic | |
| 700 | 1 | _aLeunen, Karin | |
| 700 | 1 | _aVergote, Ignace | |
| 773 | 0 |
_tGynecologic oncology _gvol. 118 _gno. 1 _gp. 64-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ygyno.2010.03.008 _zAvailable from publisher's website |
| 999 |
_c19795365 _d19795365 |
||